Cargando…
Improving the odds of drug development success through human genomics: modelling study
Lack of efficacy in the intended disease indication is the major cause of clinical phase drug development failure. Explanations could include the poor external validity of pre-clinical (cell, tissue, and animal) models of human disease and the high false discovery rate (FDR) in preclinical science....
Autores principales: | Hingorani, Aroon D., Kuan, Valerie, Finan, Chris, Kruger, Felix A., Gaulton, Anna, Chopade, Sandesh, Sofat, Reecha, MacAllister, Raymond J., Overington, John P., Hemingway, Harry, Denaxas, Spiros, Prieto, David, Casas, Juan Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906499/ https://www.ncbi.nlm.nih.gov/pubmed/31827124 http://dx.doi.org/10.1038/s41598-019-54849-w |
Ejemplares similares
-
Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012) -
Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023) -
A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service
por: Kuan, Valerie, et al.
Publicado: (2019) -
Data-driven identification of ageing-related diseases from electronic health records
por: Kuan, Valerie, et al.
Publicado: (2021) -
Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016)